Nonaka | Miyoshi | Laing | Welander | Finnish (Udd) | Markesbery-Griggs | |
---|---|---|---|---|---|---|
Inheritance | AR/sporadic | AR/sporadic | AD | AD | AD | AD |
Gene loci | 9p1-q1 | 2p12-14 | 14q11 | 2p13 | 2q31-33 | 2q31-33 |
Age at onset (y) | 20–30 | 15–30 | 4–25 | >40 | >35 | 25–50 |
Site of onset | Legs | Legs | Legs | Hands | Legs | Legs |
Leg compartment | Anterior > posterior | Posterior | Anterior | Anterior | Anterior | Anterior |
Proximal weakness | + (late) | + (late)1-150 | + | +1-151 | + (late)1-152 | + (late) |
Neck weakness | + | + (late) | + | − | − | − |
Serum creatine kinase | <X5 N | X10-100 N | <X3 N | N or mild ↑ | N or mild ↑ | X2-5 N |
EMG: | ||||||
Myopathic | + | + | + | + | + | + |
Spontaneous activity | + | + | + | + | + | + |
Biopsy: | ||||||
RVs and TFIs | + | − | − | + | + | ? |
Fibre necrosis | − | + | + | − | + | + |